Expand MRVI Menu
MRVI MENU

MRVI Stock Posts


MRVI stock declines -27.6% in premarket,

Premarket Decliner

MRVI Maravai Lifesciences Holdings - Class A7.84-0.19-2.4%

Premarket:5.68-2.16 (-27.6%)

Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research

Business WireThu, 7-Nov 4:01 PM
Upcoming Earnings

MRVI Maravai Lifesciences Holdings - Class A8.14+0.11 (+1.4%)

Maravai Lifesciences Holdings - Class A will report earnings after the market closes. View Calendar The market is expecting a ±7.2% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±28.3%. View Expected Move (Conf Call: Nov 7 5:00 PM)
Unusual Option Volume

MRVI Maravai Lifesciences Holdings - Class A9.02-0.22 (-2.4%)

Maravai Lifesciences Holdings - Class A trades 2,701 contracts. The highest volume is in the 20-Sep-24 10 calls, which is 10.9% above the current price.
View Details...
Unusual Option Volume

MRVI Maravai Lifesciences Holdings - Class A9.23-0.45 (-4.7%)

Maravai Lifesciences Holdings - Class A trades 3,409 contracts. The company has the following event: Wells Fargo Healthcare Conference on Sep 4, 2024.
View Details...
Unusual Option Volume

MRVI Maravai Lifesciences Holdings - Class A9.36+1.39 (+17.4%)

Maravai Lifesciences Holdings - Class A trades 2,102 contracts. The company has the following event: Wells Fargo Healthcare Conference on Sep 4, 2024.
View Details...
Upcoming Earnings

MRVI Maravai Lifesciences Holdings - Class A9.29+0.20 (+2.2%)

Maravai Lifesciences Holdings - Class A will report earnings after the market closes. View Calendar The market is expecting a ±8.7% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±26.8%. View Expected Move (Conf Call: Aug 7 5:00 PM)
Load Earlier Posts